{"id":"W4416634369","doi":"10.1183/13993003.congress-2025.oa6519","title":"Late Breaking Abstract - Sustained FEV1 improvements with mepolizumab up to 104 weeks in patients with COPD and less severe airflow obstruction: Post hoc analysis of the MATINEE Phase III study","year":2025,"lang":"","type":"article","venue":"","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Mepolizumab; Post-hoc analysis; Placebo; COPD; Gold standard (test); Post hoc; Lung function; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004741772,0.001124075,0.002485777,0.0001774693,0.0003526235,0.001607416,0.0008118536,0.0009803276,0.01121766],"category_scores_gemma":[0.004130073,0.0003627578,0.005446123,0.0002357419,0.0004552742,0.0008617255,0.0005520557,0.002150621,0.00181183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005221611,"about_ca_system_score_gemma":0.001111277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005540758,"about_ca_topic_score_gemma":0.001243448,"domain_scores_codex":[0.9984633,0.0008705623,0.0001126538,0.0002086655,0.0001648376,0.0001800543],"domain_scores_gemma":[0.9964651,0.001004927,0.0008491789,0.0005670172,0.0004801749,0.0006335629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9605297,0.002520685,0.004132341,0.0008463336,0.005701157,0.00005799282,0.00004682475,0.0004759532,0.00561513,0.00008725718,0.005049102,0.01493745],"study_design_scores_gemma":[0.5955876,0.2468613,0.1214302,0.0003934956,0.01332529,0.0001759013,0.00008489241,0.001604006,0.006384784,0.0004818343,0.01356894,0.0001017678],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9549083,0.01063081,0.001962891,0.003018719,0.001476671,0.004559539,0.01642558,0.0002520105,0.006765329],"genre_scores_gemma":[0.9641508,0.002022433,0.00211522,0.002858231,0.001209856,0.003263108,0.01227461,0.000130589,0.01197516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01121766,"threshold_uncertainty_score":0.03752679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008327532251832777,"score_gpt":0.2864834515989658,"score_spread":0.278155919347133,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}